Haematologic Technologies, Inc. (HTI) is a supplier that specializes in the isolation and characterization of high quality plasma proteins which are intended for in vitro research use. HTI’s emphasis is focused on proteins involved in the coagulation cascade, as well as the regulation of bone metabolism. The HTI product line consists of over 150 highly purified and well-characterized proteins including zymogens, enzymes, cofactors and inhibitors as well as a complementary line of monoclonal and polyclonal antibodies.

Major Product Lines:

• Human, Bovine and Mouse Proteins 
• Inhibitors (Corn Trypsin Inhibitor (CTI))           
• Substrates 
• Antibodies 
• Deficient Plasmas

For more information, please visit:  www.haemtech.com